Fulcrum Therapeutics
FULC
#8444
Rank
โ‚ฌ0.15 B
Marketcap
2,66ย โ‚ฌ
Share price
-4.32%
Change (1 day)
-69.15%
Change (1 year)

Revenue for Fulcrum Therapeutics (FULC)

Revenue in 2024 (TTM): โ‚ฌ74.62 Million

According to Fulcrum Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ73.92 Million. an increase over the revenue in the year 2023 that were of โ‚ฌ2.53 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Fulcrum Therapeutics from 2018 to 2024

Annual revenue

Year Revenue Change
2024 โ‚ฌ76.87 M2929.77%
2023 โ‚ฌ2.53 M-57.08%
2022 โ‚ฌ5.91 M-65.06%
2021 โ‚ฌ16.92 M135.89%
2020 โ‚ฌ7.17 M
2019 N/A
2018 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA